Particle Analytical showing new characterization and solid form capabilities at BOS 2018 Basel
Press Release | Particle Analytical ApS
JUNE 07, 2018
Hørsholm, Denmark: – Particle Analytical (PA), the Danish-based CRO that specializes in analyzing particle properties, is headed for the new Biotech Outsourcing Strategies meeting (BOS 2018)in Basel, Switzerland.
PA will use the meeting to showcase its growing capabilities in particle characterization and solid form studies, opening up new collaboration opportunities in outsourcing of Chemistry, Manufacturing and Control (CMC) processes and drug discovery.
Particle Analytical recently significantly increased its capabilities to add value to APIs and early phase medicines by acquiring dynamic vapor sorption technology, with photo documentation of analyses that allows it to investigate polymorphism and hygroscopicity in greater detail.
Solid form and characterization
Particle Analytical CEO, Søren Lund Kristensen will lead the company’s presence at the BOS meeting, accompanied by Global Technical Specialist, Dr. Dhara Raijada.
Both will be available for face to face meetings at the conference.
“We are looking forward to attending this interesting new combined event that has potential to speed progress from discovery to development,” said Mr. Kristensen.
“We at Particle Analytical have key roles to play in both CMC and Discovery outsourcing with our advanced methods and technologies for physical characterization and solid form studies,” he added.
About Particle Analytical
Particle Analytical ApS is a contract laboratory (CRO) that specializes in analysis of physical parameters of particles, powders or emulsions, using a range of advanced techniques.
Founded in year 2000, the laboratory has become one of Denmark’s most rapidly expanding companies, twice winning the national ‘Growth Gazelle’ award.
It is one of the few laboratories in Europe to offer a complete range of services dedicated to analysis of powders, including particle size, and all physical chemical properties. These services are primarily focused on the pharmaceutical industry, where particle and powder analysis are essential in controlling compound properties during development, both with regard to production process and behavior in vivo.
Unique analysis services include determination of refraction index, fast compatibility screenings of excipients and determination of the crystalline proportions of samples.
Particle Analytical’s leading-edge capabilities include laser diffraction, XRD, thermal analysis, dynamic light scattering, microscopy, BET, dynamic vapor sorption, density measurement and air permeability. The laboratory is fully certificated as cGMP compliant by the Danish authorities and is also registered with the US Food & Drug Administration (FDA).
Particle Analytical services can either be used in routine analysis, separately to solve specific problems, or in parallel to larger drug development programs. These services include particle size determination, examination of physical properties, solid form screening, method development and validation.
About BOS 2018
The Bio2Business Biotech Outsourcing Strategies 2018 meeting is a newly amalgamated partnering event for both stakeholders of CMC outsourcing and pharmaceutical discovery outsourcing.
BOS 2018 will comprise the existing Bio2Business CMC-focused event with a new discovery outsourcing component, creating an enlarged two-day conference, opening June 19 at one of Switzerland’s most modern convention centers, the Congress Center Basel.
Organizers hope the new format will provide discovery and development teams with opportunities to come together to share experience and knowledge from discovery into development.
The conference will feature Dr Brian Cox, Professor of Chemistry at University of Sussex, as keynote speaker and will comprise two modules, CMC Outsourcing and Discovery Outsourcing, both comprising numerous tracks.
The meeting also features a co-located exhibition attendee by leading international CROs and CMOs.
The meeting is organised by Bio2Business with further information at: http://www.bio2bevents.com/forthcoming-events/bos2018/.
Søren Lund Kristensen, CEO, Particle Analytical ApS
Tel: +45 4576 3060 OR +45 4011 7765